Compare Caesars Entertainment Inc (CZR) vs Tenet Healthcare Corporation (THC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Caesars Entertainment Inc vs Tenet Healthcare Corporation — how do they compare? Caesars Entertainment Inc trades at $29.55 (market cap $6.02B), while Tenet Healthcare Corporation trades at $260.93 (market cap $20.98B). The key difference: Tenet Healthcare Corporation is far larger — about 3.5× Caesars Entertainment Inc's market cap, and Tenet Healthcare Corporation is more actively traded (428,008 versus 6,412,151). Which is the better fit depends on your goals — on Pluang, investors hold Caesars Entertainment Inc for 31 Days and Tenet Healthcare Corporation for 15 Days on average.
| CZR | THC | |
|---|---|---|
Market Cap | $6.02B | $20.98B |
Volume | 6,412,151 | 428,008 |
Sector | Consumer Cyclical | Health |
52-Week High | $30.41 | $280.77 |
52-Week Low | $18.14 | $161.37 |
Typical Hold Time | 31 Days | 15 Days |
Enterprise Value | $29.91B | $32.06B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Caesars Entertainment (CZR) trades at $29.49, down 0.54% on the day, with a bearish technical signal and recent earnings misses. The company reported a net loss of -$502 million for 2025, with negative profit margins and ROE, though operating cash flow remains strong at $1.3 billion. A pending merger with Fertitta Entertainment for $31.00 per share is under regulatory review, with several law firms investigating the deal's fairness.
CZR presents a cautious outlook with merger uncertainty and persistent losses offset by stable revenue and cash generation. The consensus price target of $30.75 offers modest upside, but investors face risks from debt levels, regulatory scrutiny, and competitive pressures in the gaming sector.
Tenet Healthcare (THC) trades at $261.07, up 0.48% with strong technical momentum and bullish moving averages. The company demonstrates robust fundamentals with 82.83% gross margins and consistent earnings beats, while trading at attractive valuations including a 10.07 P/E ratio. Recent news highlights upcoming Q3 2026 earnings on October 29th and positive coverage of the company's growth prospects despite surgical volume challenges.
THC presents a compelling investment case with strong analyst support (81% buy ratings) and a $283.36 consensus target offering 8.5% upside. The healthcare provider shows improving profitability with net margins expected to reach 9.89% in 2026. Key risks include capital allocation sustainability and potential volatility around upcoming earnings, but the combination of value pricing and growth momentum supports a positive outlook.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Caesars Entertainment Inc
Caesars Entertainment includes around 50 domestic gaming properties across Las Vegas (50% of 2021 EBITDAR before corporate and digital expenses) and regional (63%) markets. Additionally, the company hosts managed properties and digital assets, the later of which produced material EBITDA losses in 2021. Caesars' U.S. presence roughly doubled with the 2020 acquisition by Eldorado, which built its first casino in Reno, Nevada, in 1973 and expanded its presence through prior acquisitions to over 20 properties before merging with legacy Caesars. Caesars' brands include Caesars, Harrah's, Tropicana, Bally's, Isle, and Flamingo. Also, the company owns the U.S. portion of William Hill (it plans to sell the international operation in 2022), a digital sports betting platform.
Read more on CZR →About Tenet Healthcare Corporation
Tenet Healthcare is a leading diversified healthcare services company that has strategically pivoted toward high-growth ambulatory care. Operating through United Surgical Partners International (USPI), the largest ambulatory platform in the U.S., Tenet manages an expansive network of surgical centers, acute care hospitals, and specialty facilities. The company’s focus on high-acuity services and operational efficiency, supported by its revenue cycle management subsidiary Conifer Health Solutions, positions it as a resilient leader in the evolving U.S. healthcare landscape.
Read more on THC →
